Net profit of Vista Pharmaceuticals reported to Rs 0.09 crore in the quarter ended March 2024 as against net loss of Rs 0.30 crore during the previous quarter ended March 2023. Sales reported to Rs 3.13 crore in the quarter ended March 2024. There were no Sales reported during the previous quarter ended March 2023.For the full year,net loss reported to Rs 4.51 crore in the year ended March 2024 as against net loss of Rs 5.66 crore during the previous year ended March 2023. Sales rose 929.00% to Rs 10.29 crore in the year ended March 2024 as against Rs 1.00 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales3.130 0 10.291.00 929 OPM %8.310 --34.69-444.00 - PBDT0.08-0.47 LP -4.46-5.25 15 PBT-0.10-0.62 84 -5.18-5.87 12 NP0.09-0.30 LP -4.51-5.66 20 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2024Powered by Capital Market - Live News

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 March 2024 .Powered by Capital Market - Live News

Net Loss of Vista Pharmaceuticals reported to Rs 1.63 crore in the quarter ended December 2023 as against net loss of Rs 0.96 crore during the previous quarter ended December 2022. Sales reported to Rs 1.70 crore in the quarter ended December 2023. There were no Sales reported during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1.700 0 OPM %-102.350 - PBDT-2.02-0.74 -173 PBT-2.20-0.89 -147 NP-1.63-0.96 -70 Powered by Capital Market - Live News

Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 February 2024. The meeting would commence at 4.30 pm.Powered by Capital Market - Live News